No deep-research provider was available; literature research done manually (PubMed MCP + cached
publications).
| PTN node | node term | n_seeds | leaf IBAs | seed annotation (term, evidence, PMID) | verdict | rationale |
|---|---|---|---|---|---|---|
| PTN005302544 | GO:0016757 glycosyltransferase activity | 2 (WbpY, WbpX) | 60 (22 taxa) | GO:0016757 glycosyltransferase activity, IMP, PMID:9680202 | INDIRECT-PHENOTYPE (term correct) | As far as the abstract and the IMP code show (full text not read), the 1998 MF assignment rests on mutant LPS phenotype plus sequence similarity, not an activity assay. The term is nevertheless true: WbpY (and WbpX) were shown in vitro to be GDP-D-Rha rhamnosyltransferases (PMID:35166992). Node conclusion sound for a GT4 clade; re-seed with IDA from PMID:35166992. |
| PTN000749272 | GO:0009103 lipopolysaccharide biosynthetic process | 1 (sole seed) | 51 (19 taxa) | GO:0009103 LPS biosynthetic process, IMP, PMID:9680202 | SOUND | Mutants lack A-band (CPA) LPS and WbpY itself catalyses a chain-extension step of the CPA O antigen, so participation in LPS biosynthesis is direct. LPS biosynthesis is a reasonable breadth for a WbbK-related GT4 subclade from O-antigen clusters; members in other species could instead make capsule or exopolysaccharide, which was not checked. |